Evolution Wealth Advisors, LLC Allakos Inc. Transaction History

Evolution Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$8.55 - $111.89 $504 - $6,601	-59 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$76.53 - $110.43 $5,127 - $7,398	-67 Reduced 53.17%	59 $6,000
Q2 2021 Jul 22, 2021	BUY	$85.37 - $114.1 $2,561 - $3,423	30 Added 31.25%	126 $11,000
Q1 2021 Apr 20, 2021	BUY	$109.73 - $153.66 $10,534 - $14,751	96 New	96 $11,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $85.6M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.